F
Francisco Marín
Researcher at University of Murcia
Publications - 503
Citations - 13444
Francisco Marín is an academic researcher from University of Murcia. The author has contributed to research in topics: Atrial fibrillation & Medicine. The author has an hindex of 53, co-authored 439 publications receiving 11660 citations. Previous affiliations of Francisco Marín include Carlos III Health Institute & Services Hospital.
Papers
More filters
Journal ArticleDOI
The SAMe-TT2R2 Score Predicts Poor Anticoagulation Control in AF Patients: A Prospective ‘Real-world’ Inception Cohort Study
Vanessa Roldán,Shirley Cancio,Josefa Gálvez,Mariano Valdés,Vicente Vicente,Francisco Marín,Gregory Y.H. Lip +6 more
TL;DR: The clinical value of the SAME-TT2R2 score is validated for the identification of patients who would have poor-quality anticoagulation, rather than imposing a "trial of vitamin K antagonists" for such patients (and exposing such patients to thromboembolic risks).
Journal ArticleDOI
The Use of Biomarkers in Clinical Management Guidelines: A Critical Appraisal.
María Asunción Esteve-Pastor,Vanessa Roldán,José Miguel Rivera-Caravaca,Inmaculada Ramírez-Macías,Gregory Y.H. Lip,Gregory Y.H. Lip,Francisco Marín +6 more
TL;DR: The aim of this review is to discuss the recommendations in clinical guidelines of various biomarkers and to review their usefulness in daily clinical practice, noting that a balance is needed between simplicity and practicality for clinical decision-making.
Journal ArticleDOI
Preoperative Statin Therapy and Troponin T Predict Early Complications of Coronary Artery Surgery
Domingo A. Pascual,Jose M. Arribas,Pedro L. Tornel,Francisco Marín,Clara Oliver,Miguel Ahumada,Jesús Gómez-Plana,Pedro Miralles Martínez,R. Arcas,Mariano Valdés +9 more
TL;DR: Preoperative statin therapy reduces early complications and offers additional protection in patients with positive troponin T status, regardless of inflammatory markers.
Journal ArticleDOI
Growth differentiation factor-15, a novel biomarker related with disease severity in patients with hypertrophic cardiomyopathy.
Silvia Montoro-García,Diana Hernández-Romero,Eva Jover,Antonio García-Honrubia,Juan Antonio Vílchez,Teresa Casas,Pedro Miralles Martínez,Vicente Climent,Luis Caballero,Mariano Valdés,Francisco Marín +10 more
TL;DR: Higher levels of GDF-15 are associated to conditions of severe disease in HCM and is suggested as a novel marker related to the severity and could represent a further useful tool in monitoring functional capacity of HCM patients.
Journal ArticleDOI
Galectin-3 as a marker of interstitial atrial remodelling involved in atrial fibrillation.
Diana Hernández-Romero,Juan Antonio Vílchez,Álvaro Lahoz,Ana I. Romero-Aniorte,Eva Jover,Arcadio García-Alberola,Rubén Jara-Rubio,Carlos Martinez,Mariano Valdés,Francisco Marín +9 more
TL;DR: Atrial fibrosis was the only independent predictor for post-operative AF occurrence in the authors' model after correcting for confounding factors, and high Gal-3 serum levels predict fibrosis of the atrial appendage.